4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001855763-22-000008
Options or other derivatives
- Chief Executive Officer acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BUNKA CHRISTOPHER Chief Executive Officer | 2022-08-29 | Grant or award · Stock Options | +30,000 | 101,001 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…